Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

PHASE2RecruitingINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

January 9, 2024

Primary Completion Date

February 24, 2027

Study Completion Date

August 11, 2027

Conditions
Pulmonary Tuberculosis
Interventions
DRUG

Ganfeborole

Oral daily dosage of 20mg.

DRUG

BTZ-043

Oral daily dosage of 1000mg.

DRUG

Bedaquiline (B)

Oral daily dosage of 400mg for the first 2 weeks, thereafter 100mg daily until end of treatment.

DRUG

Delamanid (D)

Oral daily dosage of 300mg.

DRUG

Pretomanid (Pa)

Oral daily dosage of 200mg.

DRUG

Moxifloxacin (M)

Oral daily dosage of 400mg.

DRUG

Linezolid (L)

Oral daily dosage of 600mg for the first 8 weeks.

DRUG

Pyrazinamide (Z)

Oral daily dosage of 1200mg-2000mg depending on weight.

DRUG

Rifampicin (R)

Oral daily dosage of 450mg-750mg depending on weight.

DRUG

Isoniazid (H)

Oral daily dosage of 225mg-375mg depending on weight.

DRUG

Ethambutol (E)

Oral daily dosage of 825mg-1375mg depending on weight.

DRUG

Delpazolid (DZD)

Oral daily dosage of 1200mg

DRUG

Quabodepistat (Q)

Oral daily dosage of 30mg

Trial Locations (11)

Unknown

ACTIVE_NOT_RECRUITING

"PMSI Institute of Pneumology Chiril Draganiuc", Chisinau

RECRUITING

TASK Brooklyn, Cape Town

RECRUITING

University of Cape Town Lung Institute, Cape Town

RECRUITING

TASK Eden, George

RECRUITING

NIMR Mbeya, Mbeya

RECRUITING

Kibong'oto Infectious Diseases Hospital, Moshi

RECRUITING

NIMR Mwanza, Mwanza

RECRUITING

Joint Clinical Research Centre, Kampala

RECRUITING

Makerere University Lung Institute, Kampala

ACTIVE_NOT_RECRUITING

National Lung Hospital, Hanoi

ACTIVE_NOT_RECRUITING

Pnth/Oucru, Ho Chi Minh City

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

collaborator

London School of Hygiene and Tropical Medicine

OTHER

collaborator

University of Oxford

OTHER

collaborator

Research Center Borstel

OTHER

collaborator

Lygature

UNKNOWN

collaborator

TASK Applied Science

OTHER

collaborator

Vita-Salute San Raffaele University

UNKNOWN

collaborator

Helmholtz Zentrum Munchen

UNKNOWN

collaborator

KNCV Tuberculosis Foundation

OTHER

collaborator

Critical Path Institute

UNKNOWN

collaborator

European Lung Foundation

UNKNOWN

collaborator

Instituto de Saude Publica da Universidade do Porto

OTHER

collaborator

University of Liverpool

OTHER

collaborator

Institut de Recherche pour le Developpement

OTHER_GOV

collaborator

University of Hamburg-Eppendorf

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

TB Alliance

UNKNOWN

collaborator

Find

OTHER

collaborator

University of Milano

UNKNOWN

collaborator

University of St Andrews

OTHER

collaborator

Uppsala University

OTHER

collaborator

European Respiratory Society

OTHER

collaborator

Tuberculosis Network European Trialsgroup

NETWORK

collaborator

Janssen, LP

INDUSTRY

collaborator

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

collaborator

German Center for Infection Research

OTHER

collaborator

LMU University Hospital Munich

UNKNOWN

collaborator

University of Cambridge

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

University College, London

OTHER